1AyalewTefferi,NaseemaGangat,Alexandra P.Wolanskyj,SusanSchwager,AnimeshPardanani,Terra L.Lasho,RubenMesa,Rebecca F.McClure,Chin‐YangLi,Curtis A.Hanson.20+?yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis[J].European Journal of Haematology.2008(5)
2Jitka Veselovska,Dagmar Pospisilova,Sona Pekova,Monika Horvathova,Renata Solna,Jana Cmejlova,Radek Cmejla,Monika Belickova,Vladimir Mihal,Jan Stary,Vladimir Divoky.Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro , with rare JAK2 V617F-positive erythroid colonies[J].Leukemia Research.2007(3)
3Randi Maria Luigia,Putti Maria Caterina,Scapin Margherita,Pacquola Enrica,Tucci Fabio,Micalizzi Concetta,Zanesco Luigi,Fabris Fabrizio.Pediatric patients with essential thrombocythemia are mostly polyclonal and V617FJAK2 negative[].Blood.2006
4Teofili Luciana,Giona Fiorina,Martini Maurizio,Cenci Tonia,Guidi Francesco,Torti Lorenza,Palumbo Giovanna,Amendola Angela,Leone Giuseppe,Foà Robin,Larocca Luigi M.The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia[].Blood.2007
5Giona Fiorina,Teofili Luciana,Moleti Maria Luisa,Martini Maurizio,Palumbo Giovanna,Amendola Angela,Mazzucconi Maria Gabriella,Testi Anna Maria,Pignoloni Patrizia,Orlando Sonia Maria,Capodimonti Sara,Nanni Mauro,Leone Giuseppe,Larocca Luigi Ma.Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome[].Blood.2012
6Teofili Luciana,Foà Robin,Giona Fiorina,Larocca Luigi Maria.Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients?[].Haematologica.2008
7Samuelsson Jan,Mutschler Manuel,Birgeg?rd Gunnar,Gram-Hansen Poul,Bj?rkholm Magnus,Pahl Heike L.Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia[].Haematologica.2006
